American Century Companies’s NeoGenomics NEO Stock Holding History

American Century Companies’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$944K	Buy	127,243 +55,954	+78%	+$589K	﹤0.01%	2348
2025 Q4	$838K	Buy	71,289 +49,180	+222%	+$531K	﹤0.01%	2376
2025 Q3	$171K	Sell	22,109 -3,495,369	-99%	-$24.5M	﹤0.01%	2711
2025 Q2	$25.7M	Buy	3,517,478 +197,876	+6%	+$1.6M	0.01%	968
2025 Q1	$31.5M	Buy	3,319,602 +426,341	+15%	+$5.32M	0.02%	825
2024 Q4	$47.7M	Sell	2,893,261 -132,683	-4%	-$2.06M	0.03%	657
2024 Q3	$44.6M	Sell	3,025,944 -235,812	-7%	-$3.69M	0.03%	650
2024 Q2	$45.2M	Buy	3,261,756 +167,145	+5%	+$2.37M	0.03%	615
2024 Q1	$48.6M	Buy	3,094,611 +1,103,919	+55%	+$17M	0.03%	564
2023 Q4	$32.2M	Buy	1,990,692 +1,963,810	+7,305%	+$32.1M	0.02%	681
2023 Q3	$331K	Sell	26,882 -40,211	-60%	-$598K	﹤0.01%	2426
2023 Q2	$1.08M	Buy	67,093 +20,408	+44%	+$336K	﹤0.01%	1905
2023 Q1	$798K	Buy	46,685 +15,079	+48%	+$215K	﹤0.01%	1959
2022 Q4	$292K	Buy	+31,606	New	+$295K	﹤0.01%	2223
2022 Q2	–	Sell	-370,783	Closed	-$4.5M	–	2366
2022 Q1	$4.5M	Sell	370,783 -204,557	-36%	-$4.3M	﹤0.01%	1135
2021 Q4	$19.6M	Sell	575,340 -41,313	-7%	-$1.62M	0.01%	704
2021 Q3	$29.7M	Buy	616,653 +64,886	+12%	+$3M	0.02%	585
2021 Q2	$24.9M	Sell	551,767 -2,253	-0.4%	-$99.8K	0.02%	624
2021 Q1	$26.7M	Sell	554,020 -134,906	-20%	-$7.02M	0.02%	583
2020 Q4	$37.1M	Buy	688,926 +80,487	+13%	+$3.64M	0.03%	462
2020 Q3	$22.4M	Sell	608,439 -66,080	-10%	-$2.46M	0.02%	514
2020 Q2	$20.9M	Buy	674,519 +165,912	+33%	+$4.6M	0.02%	503
2020 Q1	$14M	Buy	508,607 +25,716	+5%	+$770K	0.02%	524
2019 Q4	$14.1M	Buy	482,891 +65,059	+16%	+$1.55M	0.01%	601
2019 Q3	$7.99M	Sell	417,832 -270,791	-39%	-$6.35M	0.01%	663
2019 Q2	$15.1M	Buy	688,623 +49,977	+8%	+$1.1M	0.02%	553
2019 Q1	$13.1M	Sell	638,646 -49,129	-7%	-$854K	0.01%	560
2018 Q4	$8.67M	Buy	687,775 +380,041	+123%	+$5.66M	0.01%	638
2018 Q3	$4.72M	Buy	+307,734	New	+$4.25M	﹤0.01%	868

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

American Century Companies's NEO Position: Q1 2026 in Review

American Century Companies increased its NeoGenomics (NEO) stake by 78% in Q1 2026, buying an estimated $589K and bringing the position to 127,243 shares worth $944K. The position accounts for ﹤0.01% of the portfolio, ranked #2348.

American Century Companies first reported a position in NEO in Q3 2018 and has held it in 29 quarters since. The position peaked at $48.6M in Q1 2024. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

American Century Companies held 127,243 shares of NeoGenomics worth $944K as of Q1 2026.
American Century Companies bought 55,954 NeoGenomics shares in Q1 2026, an estimated $589K.
NeoGenomics made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2348 holding.
American Century Companies first reported a position in NeoGenomics in Q3 2018 and has held it in 29 quarters since.
American Century Companies's NeoGenomics position peaked at $48.6M in Q1 2024.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.